- The FDA is being panned for rushing out a new Omicron booster in time for the midterm elections.
- The booster “studies about efficacy, so far, have only been completed in mice,” according to a report. In fact, it was only eight mice in a Pfizer study.
- There was no human testing because, according to CDC Director Rochelle Walensky, “we will be using what I would consider to be a potentially outdated vaccine.”
Trending
COVID Booster Approved Based On 8 Mice, No Human Testing
Feds Panned For Rushing Vaccine Prior To Midterms
